The Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative, preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
We count on the support of an internationally renowned Editorial Board and strive to provide authors and reviewers with a good service and to maintain a high publication standard for our journal. In our efforts to recognize, promote, and support excellence within this multidisciplinary field, we encourage authors at all stages of their career to participate in our first Best Paper Award competition. The winner will receive a 500 Swiss Francs (CHF) cash prize that will be granted by the beginning of 2019.
What are the eligibility criteria?
- The papers must have been published between 1 January 2018 and 31 December 2018
- Only original research articles and reviews will be considered
- Regular submissions as well as Special Issue papers will be considered
What criteria will be considered by the Best Paper Award Committee?
- Contributions to, and advancement of the field
- Quality of presentation
- Scientific soundness
How to participate?
- Submit your paper to the Journal of Personalized Medicine through our submission system at https://susy.mdpi.com
Travel Award 2017
She performs research on the genetics of mood disorders and pharmacogenetics of antidepressants at Bologna University and she spent one year as visiting researcher at the Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN) King’s College London. She has co-authored around 50 papers published in international peer-reviewed journals. WINNER 2017 TRAVEL AWARD
On behalf of JPM, she will be awarded 800 Swiss Francs to attend the 17th World Congress of Psychiatry that will be held 8–12 October 2017 in Berlin, Germany. There, she will present her work on “Pharmacogenomic meta-analysis of antidepressant treatment response in GENDEP and STAR*D” as an oral presentation in the symposium entitled Pharmacogenomics of Mood Disorders.
Travel Award 2016
Claudia Ojeda-Granados is a third-year Ph.D. student in Molecular Biology in the Medicine Doctoral Program at the Universidad of Guadalajara, Mexico. She has been involved in both basic and clinical protocols regarding nutrigenetics and nutritional intervention therapy in patients with liver disease since 2013 and she has already co-authored more than ten publications in the field. On behalf of JPM, she will be awarded 800 Swiss Francs to attend the HGM2017 “From Genomics to Therapy” that will be held 5–7 February 2017 in Barcelona, Spain. There, she will present her work on “Nutritional Genomic Therapy as an Intervention Strategy in Patients with Obesity from West Mexico”.